BST:46K

Stock Analysis Report

Executive Summary

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.

Snowflake

Fundamentals

Flawless balance sheet with high growth potential.

Risks

  • IRadimed is covered by less than 3 analysts.

Similar Companies

Share Price & News

How has IRadimed's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

BST:46K

3.7%

DE Medical Equipment

3.2%

DE Market


1 Year Return

n/a

BST:46K

4.5%

DE Medical Equipment

-9.7%

DE Market

No trading data on 46K.

No trading data on 46K.


Share holder returns

46KIndustryMarket
7 Day0%3.7%3.2%
30 Day0%-1.5%-4.4%
90 Day-2.4%3.4%-2.0%
1 Yearn/a6.2%4.5%-6.9%-9.7%
3 Yearn/a118.2%112.4%11.8%2.2%
5 Yearn/a268.4%250.0%26.9%9.5%

Price Volatility Vs. Market

How volatile is IRadimed's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is IRadimed undervalued based on future cash flows and its price relative to the stock market?

28.31x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

IRadimed's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

IRadimed's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

IRadimed is good value based on earnings compared to the DE Medical Equipment industry average.

IRadimed is overvalued based on earnings compared to the Germany market.


Price Based on Expected Growth

IRadimed is good value based on expected growth next year.


Price Based on Value of Assets

IRadimed is good value based on assets compared to the DE Medical Equipment industry average.


Next Steps

Future Growth

How is IRadimed expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

29.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

IRadimed's revenue is expected to grow significantly at over 20% yearly.

IRadimed's earnings are expected to grow significantly at over 20% yearly.

IRadimed's revenue growth is expected to exceed the Germany market average.

IRadimed's earnings growth is expected to exceed the Germany market average.

IRadimed's earnings growth is expected to exceed the low risk savings rate of 0.2%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if IRadimed will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has IRadimed performed over the past 5 years?

6.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

IRadimed's year on year earnings growth rate has been positive over the past 5 years.

IRadimed's 1-year earnings growth exceeds its 5-year average (212.6% vs 6.5%)

IRadimed's earnings growth has exceeded the DE Medical Equipment industry average in the past year (212.6% vs 10.8%).


Return on Equity

IRadimed has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

IRadimed used its assets more efficiently than the DE Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

IRadimed's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is IRadimed's financial position?


Financial Position Analysis

IRadimed is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

IRadimed's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

IRadimed has no debt.

IRadimed currently has no debt however we can't compare to 5 years ago as we have no data for that period.

IRadimed has no debt, it does not need to be covered by operating cash flow.

IRadimed has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Low level of unsold assets.

IRadimed has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is IRadimed's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate IRadimed's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate IRadimed's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as IRadimed has not reported any payouts.

Unable to verify if IRadimed's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as IRadimed has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of IRadimed's salary, the management and board of directors tenure and is there insider trading?

7.6yrs

Average management tenure


CEO

Leslie McDonnell (46yo)

0.0yrs

Tenure

0

Ms. Leslie L. McDonnell has been Vice President and General Manager of Newborn Care Business Unit at Natus Medical Incorporated since joining it on February 12, 2018. Ms. McDonnell served as Global Busines ...


Management Age and Tenure

7.6yrs

Average Tenure

62yo

Average Age

The average tenure for the IRadimed management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

3.3yrs

Average Tenure

66yo

Average Age

The tenure for the IRadimed board of directors is about average.


Insider Trading

IRadimed individual insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$511,25306 Aug 19
Louis Waldman
EntityIndividual
Role
Controller
Controller
Shares25,000
Max PriceUS$21.18
SellUS$32,64806 Mar 19
Steve Nardi
EntityIndividual
Shares1,418
Max PriceUS$23.02
SellUS$1,381,77917 Sep 18
Francis Casey
EntityIndividual
Shares55,000
Max PriceUS$26.16

Ownership Breakdown


Management Team

  • Roger Susi (66yo)

    Founder

    • Tenure: 3.2yrs
    • Compensation: US$494.58k
  • Brent Johnson (60yo)

    Executive Vice President of Worldwide Sales & Marketing

    • Tenure: 7.6yrs
    • Compensation: US$453.91k
  • Chris Scott (49yo)

    CFO & Secretary

    • Tenure: 5.7yrs
    • Compensation: US$508.45k
  • Louis Waldman (64yo)

    Controller

    • Tenure: 14.6yrs
  • John McCreery (64yo)

    Chief Operating Officer

    • Tenure: 2.3yrs
    • Compensation: US$436.56k
  • Leslie McDonnell (46yo)

    President

    • Tenure: 0.0yrs

Board Members

  • Jim Hawkins (63yo)

    Director

    • Tenure: 0.2yrs
    • Compensation: US$35.50k
  • Roger Susi (66yo)

    Founder

    • Tenure: 3.2yrs
    • Compensation: US$494.58k
  • Anthony Vuoto (68yo)

    Independent Director

    • Tenure: 3.4yrs
    • Compensation: US$152.50k
  • Monty Allen (66yo)

    Independent Director

    • Tenure: 5.6yrs
    • Compensation: US$155.00k
  • Leslie McDonnell (46yo)

    President

    • Tenure: 0.0yrs

Company Information

IRadimed Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IRadimed Corporation
  • Ticker: 46K
  • Exchange: BST
  • Founded: 1992
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$235.462m
  • Listing Market Cap: US$212.199m
  • Shares outstanding: 11.37m
  • Website: https://www.iradimed.com

Number of Employees


Location

  • IRadimed Corporation
  • 1025 Willa Springs Drive
  • Winter Springs
  • Florida
  • 32708
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IRMDNasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDJul 2014
46KBST (Boerse-Stuttgart)YesCommon SharesDEEURJul 2014
46KDB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2014

Biography

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationa ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/21 22:34
End of Day Share Price2019/06/12 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.